Bravelle is a fertility medication primarily used in women to stimulate ovulation. It contains highly purified urofollitropin, a form of human follicle-stimulating hormone (FSH), which is essential for the growth and development of ovarian follicles, ultimately leading to the release of an egg. Bravelle is often prescribed for women who have difficulty ovulating on their own and is used as part of assisted reproductive technologies such as in vitro fertilization (IVF). It is administered through subcutaneous injections under the guidance of a healthcare professional. The dosage and duration of treatment with Bravelle depend on the individual's response to the medication, which is monitored through ultrasound and hormone levels.